Medium materiality5/10
KeyBanc raises Encompass Health price target to $150
Why it may matterVerify against the original reporting
Bullish, with same-day analyst corroboration; targets remain opinions.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
KeyBanc raised its EHC price target to $150, about 14% above the cited $131.49 price. A second analyst target increase for EHC was reported the same morning.
- Raised target: $150
- Cited price: $131.49
Key facts
- 01
Target: $150
- 02
Posted price: $131.49
- 03
Analyst firm: KeyBanc
- 04
Analyst: Matthew Gillmor
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.